DOTA-LM3 TFA

CAT: 0931-T78110-01Size: 5 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0931-T78110-01Size:5 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Target

Somatostatin, Others

Related Pathways

GPCR/G Protein, Others

Bioactivity

DOTA-LM3 TFA is a somatostatin receptor (SSTR) antagonist with the molecular structure p-Cl-Phe-cyclo (D-Cys-Tyr-D-4-amino-Phe (carbamoyl) -Lys-Thr-Cys) D-Tyr-NH2, used for in vivo tumor tracing via isotopic labeling, such as 177Lu-DOTA-LM3 TFA and 68Ga-DOTA-LM3 TFA. The 68Ga-labeled compound shows favorable biodistribution, high tumor uptake, good tumor retention, and minimal safety concerns, while the 177Lu-labeled variant targets DOTATOC-negative liver metastases, including pancreatic NET and extensive tumor thrombosis [1] [2].

Molecular Formula

C71H94ClF3N16O21S2

Molecular Weight

1664.18

Shipping Conditions

Ice Packs

Storage Temperature

-20°C

Related Products

Catalog	Name
T80155-01	DOTA-LM3
T80238-01	NODAGA-LM3 TFA
TSH-00303-01	DOTA-ADIBO TFA
TP3068-01	DOTA-Octreotide TFA
T200139-01	DOTA-NHS-ester TFA
T201168-01	C (avb6) -DOTA TFA
T88940-01	DOTA.SA.FAPi TFA
TP3867-01	DOTA-Pep-1L TFA
TSH-00330-01	DOTA-NHS-ester hexafluorophosphate TFA
TP3690-01	DOTA-Bombesin (1-14) TFA

Alternative Products

Catalog	Name
HY-P5126-01	DOTA-LM3
A23503-10	DOTA-LM3 10mg
HY-P5126A-01	DOTA-LM3 (TFA)
MBS5819780	DOTA-LM3 TFA
A23503-5	DOTA-LM3 5mg
A23503-1	DOTA-LM3 1mg
MBS5821896	NODAGA-LM3
MBS5821897	NODAGA-LM3 TFA
HY-P5362A	NODAGA-LM3 (TFA)
GTR19267069-01	DOTA-Tyr-Lys-DOTA

DOTA-LM3 TFA

Related Products

Alternative Products

Popular Products